Bridging Science to Outcomes, Across the World
SouthBridge Advisory
We help biopharma companies navigate the complex path from breakthrough science to real-world patient impact. Our focus is on advanced therapies — cell & gene therapies and biologics — and on unlocking access in the world’s fastest-growing but most challenging markets.
Book a ConsultationLearn MoreDriving Patient Access and Commercial Success in Advanced Therapies
SouthBridge Advisory is a boutique consulting firm that combines global experience with deep emerging market expertise. We specialize in helping companies transform innovation into impact by bridging science, access, and commercialization. With decades of leadership in biologics and cell & gene therapies, we design strategies that accelerate time-to-market, expand patient access, and create sustainable growth. Our mission is simple but ambitious: to ensure that life-changing therapies reach patients everywhere, not just in Tier-1 markets.
Execution, Not Theory
We have led real-world launches, built commercial teams, and negotiated directly with payers, hospitals, and regulators. This means our advice is grounded in practical experience and tested under the toughest conditions.
Proven Track Record
SouthBridge has been at the forefront of some of the most significant commercialization milestones in emerging markets. From bringing India’s first CAR-T therapy to patients to building multi-million-dollar biologics portfolios across Asia, we have consistently delivered outcomes that can be measured in access, adoption, and revenue.
Emerging Markets Focus
While many global firms glance at emerging markets, we live and breathe them. We know the affordability barriers, reimbursement bottlenecks, and policy hurdles that make or break launches. This unique focus allows us to design solutions that are realistic, locally tailored, and globally scalable.
End-to-End Expertise
We understand the entire value chain of advanced therapies — from early clinical development to market entry and lifecycle management. Our expertise spans regulatory pathways, pricing and reimbursement, commercial operations, and medical engagement. This integration ensures that our strategies do not stop at the whiteboard but move seamlessly into execution.
Our Core Services
Strategic Advisory Across the Biopharma Value Chain
Strategic Advisory Across the Biopharma Value Chain
Market Entry & Go-to-Market Strategy
We build data-driven, evidence-based strategies for market entry that balance patient affordability with long-term commercial viability. Our experience across more than ten launches in emerging markets means we know how to design approaches that withstand scrutiny from regulators, payers, and boards. With SouthBridge, your go-to-market strategy becomes a blueprint for execution, not just an idea on paper.
Cell & Gene Therapy Commercialization
Few firms can match our end-to-end expertise in CGT. We understand the scientific complexity of these therapies, the specialized hospital infrastructure required, and the political and economic barriers that determine adoption. Our work on India’s first CAR-T launch proves that we can turn pioneering science into accessible reality. For clients, this means we are not learning on your time — we already know what works.
Pricing, Access & Reimbursement Strategy
Pricing is where innovation succeeds or fails. We help companies design pricing models that expand affordability without destroying value. From outcome-based contracts and milestone payments to pooled procurement strategies, our solutions are practical, defensible, and tailored to the constraints of emerging markets. We believe access and commercial success are not opposites — they are two sides of the same coin.
Interim Commercial Leadership & Advisory Boards
Sometimes the missing link is leadership. SouthBridge can step in as your fractional Chief Business Officer or Commercial Head, guiding strategy and execution during critical phases. We also design and run scientific and commercial advisory boards that bring in the right external expertise. With us, you don’t just get advice — you get leadership that drives results.
Strategic Workshops, Landscape Assessments & Due Diligence
Big investments require big decisions — and those require clarity. We design and deliver deep-dive workshops and market landscape assessments that cut through noise and give you a clear picture of opportunity and risk. Our KOL-driven insights have guided multi-million-dollar investments and portfolio choices. For investors and companies alike, we provide the confidence to act.
Accelerate Your Therapy’s Market Journey
Commercializing advanced therapies is one of the most complex challenges in healthcare. SouthBridge helps you navigate this journey with precision, speed, and confidence. We partner with biopharma leaders to design and execute market strategies that reduce time-to-market, expand patient access, and deliver commercial success.
Book a Consultation for Your Therapy Launch
Partner with our experts to design market-ready strategies that accelerate patient access to your advanced therapy.
Go-to-market & PSP Expertise
Building Market-Ready Therapies with Patient-Centric Execution
Launch Readiness & Go-to-Market Planning
Designing and executing comprehensive GTM frameworks covering brand positioning, pricing, channel strategy, and stakeholder engagement.
Branding & Visual Identity Development
Co-creating brand identity for biologics & CGT products in partnership with leading global branding agencies, ensuring global compliance and strong recall among HCPs & patients.
Cross-Functional Launch Readiness & Dashboarding
Tracking & monitoring CFT preparedness across all functions (regulatory, medical, manufacturing, supply chain, commercial) using dashboards with leading & lagging indicators.
Medical Affairs Leadership
Directing medical affairs strategy for CGT and biologics, including KOL engagement, treatment protocol development, and medical education programs, ensuring evidence-based positioning and clinical adoption.
Additional Services
Commercial Operations & Digital Enablement
We build the systems that make commercialization scalable. This includes CRM solutions for patient tracking, dashboards for launch readiness, and frameworks for supply chain excellence. Digital enablement turns strategy into measurable execution.
4-Phase Approach (Development → Post-Launch)
Plan your commercial activities based on your development stage
Phase 1 – Early Development
We help you understand the landscape from day one. This includes epidemiology scans, competitor benchmarking, and positioning strategies that set your pipeline up for success. By identifying opportunities early, we de-risk development and sharpen future commercial decisions.
Phase 2 – Mid-Development
As programs mature, access and affordability become critical. We prioritize target markets, map regulatory and payer pathways, and initiate early stakeholder engagement. This ensures that by the time your therapy is ready for approval, the system is ready for you.
Phase 3 – Late Dev. to Launch
We design and execute go-to-market strategies that cover pricing, access, medical engagement, and operational readiness. Our proven frameworks align cross-functional teams and ensure no gaps between regulatory approval and commercial availability. This is where strategy turns into action.
Phase 4 – Post-Launch
Commercial success does not end with launch. We help you manage the lifecycle of your therapy, expand into new indications or geographies, and build sustainable partnerships. Our focus is on ensuring long-term adoption, not just first-year sales.
Why SouthBridge?
The SouthBridge Advantage – Pragmatic, Execution-Focused
Consulting
Hands-On Experience, Not Just Advice
At SouthBridge, we have lived the challenges of bringing advanced therapies to market. We have led global launches, built hospital networks, and sat across the table from payers. This firsthand experience means we know the pitfalls and levers that theory alone cannot teach.
End-to-End Commercialization Expertise
From early portfolio decisions to post-launch lifecycle management, we cover the entire commercialization journey. Our integrated approach ensures continuity, so you don’t have to stitch together fragmented advice from multiple firms.
Ready to accelerate your therapy’s market journey?
Partner with SouthBridge to turn strategy into execution and bring your advanced therapy to patients faster.
Engagement models
Work With Us the Way That Works Best for You
Project-Based Advisory
For specific challenges — from pricing models to market-entry plans — we deliver targeted, time-bound solutions. This ensures rapid clarity and actionable outcomes without long-term commitment.
Retainer-Based Strategic Partnering
Some clients need sustained leadership without the overhead of a full-time hire. As your fractional CBO, we provide strategic direction and execution oversight on an ongoing basis.
Workshops & Capability Building
We run immersive workshops that strengthen internal capabilities. Topics include access strategy, pricing frameworks, competitive intelligence, and KOL engagement. These sessions equip teams to think and act strategically long after the workshop ends.
Due Diligence & Investor Support
Investors need confidence before committing capital. We deliver market assessments, competitor scans, and feasibility analyses that de-risk investments. Our insights have shaped multi-million-dollar decisions in advanced therapies.
Testimonial
People like us, officially
Trusted by biopharma leaders, medical experts, and investors worldwide for delivering real-world commercialization success in advanced therapies.
Let’s bridge science and patient access together
With over 25 years of experience in advanced therapies, SouthBridge helps companies navigate one of the most complex challenges in healthcare. Whether it’s market entry, pricing design, or commercial execution, we provide clarity, direction, and leadership.